HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 208: | Line 208: | ||
|Acute promyelocytic leukaemia with PML::RARA fusion | |Acute promyelocytic leukaemia with PML::RARA fusion | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 216: | Line 216: | ||
| | | | ||
| | | | ||
| | |Acute Promyelocytic Leukemia (APL) with PML-RARA | ||
| | |Yiming Zhong, Ph.D., Megan Piazza, Ph.D., and Shashi Shetty, Ph.D. | ||
| | |Complete | ||
| | |03/01/2021-MS (re-review) | ||
| | | | ||
|- | |- | ||
|Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion | |Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 232: | Line 232: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | ||
| | |Christine Bryke, MD<br>Beth Israel Deaconess Medical Center, Boston, MA | ||
| | |Complete | ||
| | |04/26/2021-MS (re-review) | ||
| | | | ||
|- | |- | ||
|Acute myeloid leukaemia with CBFB::MYH11 fusion | |Acute myeloid leukaemia with CBFB::MYH11 fusion | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 248: | Line 248: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | ||
| | |Christine Bryke, MD <br> Beth Israel Deaconess Medical Center, Boston, MA | ||
| | |Complete | ||
| | |03/01/2021-MS (re-review) | ||
| | | | ||
|- | |- | ||
| Line 264: | Line 264: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 | ||
| | |Jennelle C. Hodge, PhD, FACMG | ||
| | |Complete | ||
| | |02/24/2021-MS (re-review) | ||
| | | | ||
|- | |- | ||
|Acute myeloid leukaemia with RBM15::MRTFA fusion | |Acute myeloid leukaemia with RBM15::MRTFA fusion | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 280: | Line 280: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 | ||
| | |Jennelle C. Hodge, PhD, FACMG | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 288: | Line 288: | ||
|Acute myeloid leukaemia with BCR::ABL1 fusion | |Acute myeloid leukaemia with BCR::ABL1 fusion | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 296: | Line 296: | ||
| | | | ||
| | | | ||
| | |Acute Myeloid Leukemia (AML) with BCR-ABL1 | ||
| | |Kay Weng Choy MBBS, Monash Medical Centre | ||
| | |Complete | ||
| | | | ||
| | | | ||